Lumen (LUMN) unveils a multi-year growth plan to boost EBITDA margins and free cash flow, driven by AI investment and fiber deals.

Ouster's robust cash reserves and DoD contract provide resilience amid industry volatility and ongoing market consolidation.

Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Taneia Surles is health and wellness writer and public health professional that has been creating health and wellness content since 2020. Her writing has covered several verticals, including sexual ...